Skip to main content

Ra Medical Systems, Inc. (RMED)

1.74 -0.15 (-7.71%)
Dec 3, 2021 4:00 PM EST - Market closed

Company Description

Ra Medical Systems, Inc., a commercial-stage medical device company, develops, manufactures, and markets excimer lasers for use in the treatment of vascular and dermatological immune-mediated inflammatory diseases.

The company offers DABRA (destruction of arteriosclerotic blockages by laser radiation ablation), a minimally-invasive excimer laser and single-use catheter system that is used by physicians in the endovascular treatment of vascular blockages resulting from lower extremity vascular disease.

It also provides Pharos, an excimer laser device that emits highly concentrated ultraviolet light and is used as a tool in the treatment of dermatological skin disorders.

The company sells its products primarily through its direct sales force in the United States. Ra Medical Systems, Inc. was incorporated in 2002 and is headquartered in Carlsbad, California.

Ra Medical Systems, Inc.
Ra Medical Systems Logo
CountryUnited States
IPO DateAug 30, 2018
IndustryHealth Care Equipment & Supplies
SectorHealth Care

Contact Details

2070 Las Palmas Dr
Carlsbad, California 92011-1518
United States
Phone760 804 1648

Stock Details

Ticker SymbolRMED
Fiscal YearJanuary - December
Reporting CurrencyUS Dollars
CIK Code0001716621

Key Executives

Jonathan Will McGuireChief Executive Officer and Director
Andrew C. JacksonChief Financial Officer
Tiah ReppasVice President, Chief Accounting Officer and Corporate Controller
Maria Villanueva SessionsVice President and Compliance Officer

Latest SEC Filings

Nov 24, 20214Statement of changes in beneficial ownership of securities
Nov 24, 20214Statement of changes in beneficial ownership of securities
Nov 15, 202110-QQuarterly report [Sections 13 or 15(d)]
Nov 15, 20218-KCurrent report
Aug 24, 20218-KCurrent report
Aug 16, 20218-KCurrent report
Aug 16, 20218-KCurrent report
Aug 11, 202110-QQuarterly report [Sections 13 or 15(d)]
Aug 5, 20218-KCurrent report
Aug 4, 2021424B3Prospectus [Rule 424(b)(3)]
View All SEC Filings